Old National Bancorp Has Trimmed By $812,404 Its Exxon Mobil (XOM) Holding; Five Prime Therapeutics (FPRX) Has 1.34 Sentiment

April 23, 2018 - By Stephen Andrade

Exxon Mobil Corporation (NYSE:XOM) Logo

Old National Bancorp decreased Exxon Mobil Corp (XOM) stake by 2.9% reported in 2017Q4 SEC filing. Old National Bancorp sold 9,788 shares as Exxon Mobil Corp (XOM)’s stock declined 12.23%. The Old National Bancorp holds 327,683 shares with $27.41 million value, down from 337,471 last quarter. Exxon Mobil Corp now has $335.17B valuation. The stock increased 0.16% or $0.127 during the last trading session, reaching $79.127. About 3.21 million shares traded. Exxon Mobil Corporation (NYSE:XOM) has declined 9.29% since April 23, 2017 and is downtrending. It has underperformed by 20.84% the S&P500.

Five Prime Therapeutics Inc (FPRX) investors sentiment increased to 1.34 in 2017 Q4. It’s up 0.30, from 1.04 in 2017Q3. The ratio improved, as 67 active investment managers opened new and increased stock positions, while 50 sold and trimmed equity positions in Five Prime Therapeutics Inc. The active investment managers in our database now hold: 25.47 million shares, up from 23.96 million shares in 2017Q3. Also, the number of active investment managers holding Five Prime Therapeutics Inc in top ten stock positions was flat from 0 to 0 for the same number . Sold All: 21 Reduced: 29 Increased: 43 New Position: 24.

Old National Bancorp increased Dst Sys Inc Del (NYSE:DST) stake by 6,822 shares to 14,772 valued at $917,000 in 2017Q4. It also upped Vanguard Index Fds (VBR) stake by 3,687 shares and now owns 43,052 shares. Intuitive Surgical Inc (NASDAQ:ISRG) was raised too.

Investors sentiment decreased to 0.84 in 2017 Q4. Its down 0.01, from 0.85 in 2017Q3. It fall, as 48 investors sold XOM shares while 819 reduced holdings. 123 funds opened positions while 603 raised stakes. 2.17 billion shares or 1.92% more from 2.13 billion shares in 2017Q3 were reported. Efg Asset Mngmt (Americas) Corp invested 0.27% in Exxon Mobil Corporation (NYSE:XOM). B T Cap Management Dba Alpha Cap Management owns 54,126 shares or 2.14% of their US portfolio. Norinchukin Financial Bank The invested in 0.95% or 648,853 shares. Troy Asset holds 0.03% or 8,000 shares in its portfolio. Birinyi Associates holds 0.47% or 12,660 shares in its portfolio. Coastline Trust accumulated 40,028 shares or 0.5% of the stock. Regal Invest Advsr Ltd Liability invested in 0.75% or 40,395 shares. Jacobs Levy Equity Management, a New Jersey-based fund reported 530,475 shares. Northside Mngmt Ltd Limited Liability Company has 0.15% invested in Exxon Mobil Corporation (NYSE:XOM) for 6,362 shares. Jnba Fincl holds 0.37% of its portfolio in Exxon Mobil Corporation (NYSE:XOM) for 21,180 shares. Gsa Partners Ltd Liability Partnership holds 10,022 shares. Mitchell Sinkler And Starr Pa reported 3.69% in Exxon Mobil Corporation (NYSE:XOM). Atlantic Grp Inc Incorporated Limited Co owns 905,837 shares. Eaton Vance Mngmt invested 1.18% in Exxon Mobil Corporation (NYSE:XOM). The Texas-based Texas Permanent School Fund has invested 1.21% in Exxon Mobil Corporation (NYSE:XOM).

Since December 11, 2017, it had 0 buys, and 4 selling transactions for $3.42 million activity. $996,628 worth of Exxon Mobil Corporation (NYSE:XOM) shares were sold by Chapman Neil A. Corson Bradley W also sold $1.62M worth of Exxon Mobil Corporation (NYSE:XOM) shares. 2,412 shares were sold by Wascom Dennis G, worth $200,293. $606,082 worth of Exxon Mobil Corporation (NYSE:XOM) shares were sold by Milton Bryan W.

Among 26 analysts covering Exxon Mobil (NYSE:XOM), 10 have Buy rating, 6 Sell and 10 Hold. Therefore 38% are positive. Exxon Mobil had 92 analyst reports since July 22, 2015 according to SRatingsIntel. The stock of Exxon Mobil Corporation (NYSE:XOM) has “Buy” rating given on Thursday, March 8 by Bank of America. As per Wednesday, December 20, the company rating was maintained by Jefferies. Jefferies maintained it with “Neutral” rating and $92 target in Friday, April 7 report. Jefferies maintained it with “Hold” rating and $81.0 target in Tuesday, October 3 report. Jefferies maintained it with “Hold” rating and $90.0 target in Friday, January 19 report. The stock of Exxon Mobil Corporation (NYSE:XOM) has “Underperform” rating given on Wednesday, November 18 by Raymond James. On Tuesday, January 23 the stock rating was maintained by Piper Jaffray with “Hold”. The firm earned “Sell” rating on Tuesday, January 26 by Tudor Pickering. The rating was maintained by TD Securities with “Hold” on Thursday, August 6. The company was maintained on Wednesday, January 24 by Morgan Stanley.

Analysts await Exxon Mobil Corporation (NYSE:XOM) to report earnings on April, 27 before the open. They expect $1.18 EPS, up 24.21% or $0.23 from last year’s $0.95 per share. XOM’s profit will be $5.00B for 16.76 P/E if the $1.18 EPS becomes a reality. After $0.88 actual EPS reported by Exxon Mobil Corporation for the previous quarter, Wall Street now forecasts 34.09% EPS growth.

Awm Investment Company Inc. holds 0.64% of its portfolio in Five Prime Therapeutics, Inc. for 150,000 shares. Bb Biotech Ag owns 827,500 shares or 0.51% of their US portfolio. Moreover, Rock Springs Capital Management Lp has 0.42% invested in the company for 425,000 shares. The Massachusetts-based Eventide Asset Management Llc has invested 0.36% in the stock. Granite Point Capital Management L.P., a Massachusetts-based fund reported 80,000 shares.

The stock increased 2.54% or $0.41 during the last trading session, reaching $16.55. About 67,983 shares traded. Five Prime Therapeutics, Inc. (FPRX) has declined 52.34% since April 23, 2017 and is downtrending. It has underperformed by 63.89% the S&P500.

Analysts await Five Prime Therapeutics, Inc. (NASDAQ:FPRX) to report earnings on May, 3. They expect $-0.54 earnings per share, up 55.37% or $0.67 from last year’s $-1.21 per share. After $-1.04 actual earnings per share reported by Five Prime Therapeutics, Inc. for the previous quarter, Wall Street now forecasts -48.08% EPS growth.

Five Prime Therapeutics, Inc. (NASDAQ:FPRX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Stephen Andrade

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: